In a Polish magazine interview, Prof. Ewa Pańkowska, Medical Director at the Institute of Diabetology, highlights the crucial role of clinical research, specifically focusing on the DIAGNODE-3 study.

Addressing type 1 diabetes, she emphasizes autoimmune complexities, underscores the vital early detection, and outlines ongoing efforts to preserve beta cells and diminish insulin dependency using GAD-targeted immunotherapy for newly diagnosed patients.

Read the interview here